BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12411319)

  • 1. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow.
    Hofmann WK; de Vos S; Komor M; Hoelzer D; Wachsman W; Koeffler HP
    Blood; 2002 Nov; 100(10):3553-60. PubMed ID: 12411319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome.
    Vasikova A; Budinska E; Belickova M; Cermak J; Bruchova H
    Neoplasma; 2009; 56(4):335-42. PubMed ID: 19469654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome.
    Prall WC; Czibere A; Grall F; Spentzos D; Steidl U; Giagounidis AAN; Kuendgen A; Otu H; Rong A; Libermann TA; Germing U; Gattermann N; Haas R; Aivado M
    Int J Hematol; 2009 Mar; 89(2):173-187. PubMed ID: 19152102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
    Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34(+) cells selected from patients with both low- and high-risk myelodysplastic syndrome.
    Gueller S; Komor M; Nowak D; Baldus CD; de Vos S; Hoelzer D; Ottmann OG; Hofmann WK
    Exp Hematol; 2010 Sep; 38(9):718-32, 732.e1-6. PubMed ID: 20621626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of TET2 in CD3⁺ and CD34⁺ cells of myelodysplastic syndromes and enhances CD34⁺ cells proliferation.
    Zhang W; Shao Z; Fu R; Wang H; Li L; Liu H
    Int J Clin Exp Pathol; 2015; 8(9):10840-6. PubMed ID: 26617797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression in CD34(+) cells from normal bone marrow and leukemic origins.
    Gu J; Zhang QH; Huang QH; Ren SX; Wu XY; Ye M; Huang CH; Fu G; Zhou J; Niu C; Han ZG; Chen SJ; Chen Z
    Hematol J; 2000; 1(3):206-17. PubMed ID: 11920191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Dostalova Merkerova M; Krejcik Z; Votavova H; Belickova M; Vasikova A; Cermak J
    Eur J Hum Genet; 2011 Mar; 19(3):313-9. PubMed ID: 21150891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.
    Li X; Marcondes AM; Gooley TA; Deeg HJ
    Blood; 2010 Sep; 116(13):2304-14. PubMed ID: 20562331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
    Pellagatti A; Benner A; Mills KI; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Verma A; McDonald EJ; Killick S; Hellström-Lindberg E; Bullinger L; Wainscoat JS; Boultwood J
    J Clin Oncol; 2013 Oct; 31(28):3557-64. PubMed ID: 24002510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine.
    Giachelia M; D'Alò F; Fabiani E; Saulnier N; Di Ruscio A; Guidi F; Hohaus S; Voso MT; Leone G
    Leuk Res; 2011 Apr; 35(4):465-71. PubMed ID: 20869114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
    Pellagatti A; Cazzola M; Giagounidis AA; Malcovati L; Porta MG; Killick S; Campbell LJ; Wang L; Langford CF; Fidler C; Oscier D; Aul C; Wainscoat JS; Boultwood J
    Blood; 2006 Jul; 108(1):337-45. PubMed ID: 16527891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
    Tauro S; Hepburn MD; Bowen DT; Pippard MJ
    Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS Patients.
    Langemeijer SM; Mariani N; Knops R; Gilissen C; Woestenenk R; de Witte T; Huls G; van der Reijden BA; Jansen JH
    PLoS One; 2016; 11(11):e0165582. PubMed ID: 27902785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in patients with myelodysplastic syndromes: differential involvement of marrow cells in 'good' versus 'poor' prognosis patients and correlation with apoptosis-related genes.
    Tsoplou P; Kouraklis-Symeonidis A; Thanopoulou E; Zikos P; Orphanos V; Zoumbos NC
    Leukemia; 1999 Oct; 13(10):1554-63. PubMed ID: 10516757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes.
    Vasilatou D; Papageorgiou SG; Kontsioti F; Kontos CK; Tsiotra P; Mpakou V; Pavlou MA; Economopoulou C; Dimitriadis G; Dervenoulas J; Pappa V
    Leuk Res; 2013 Mar; 37(3):251-8. PubMed ID: 23246221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.
    Chen G; Zeng W; Miyazato A; Billings E; Maciejewski JP; Kajigaya S; Sloand EM; Young NS
    Blood; 2004 Dec; 104(13):4210-8. PubMed ID: 15315976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancy in transcriptomic profiling between CD34 + stem cells and primary bone marrow cells in myelodysplastic neoplasm.
    Ribeiro Junior HL; Gonçalves PG; Moreno DA; Goes JVC; de Oliveira RTG; Montefusco-Pereira CV; Komoto TT; Pinheiro RF
    Leuk Res; 2023 Jun; 129():107071. PubMed ID: 37004280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrow.
    Van Dijk JP; Knops GH; Van De Locht LT; Menke AL; Jansen JH; Mensink EJ; Raymakers RA; De Witte T
    Br J Haematol; 2002 Sep; 118(4):1027-33. PubMed ID: 12199781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.